Publication | Open Access
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
39
Citations
33
References
2021
Year
ClinicalTrials.gov NCT01988493.
| Year | Citations | |
|---|---|---|
Page 1
Page 1